nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—Pain in extremity—Sorafenib—liver cancer	0.0107	0.0109	CcSEcCtD
Carbidopa—Venous thrombosis—Epirubicin—liver cancer	0.0101	0.0103	CcSEcCtD
Carbidopa—Nasopharyngitis—Sorafenib—liver cancer	0.00957	0.00975	CcSEcCtD
Carbidopa—Gastritis—Sorafenib—liver cancer	0.00947	0.00965	CcSEcCtD
Carbidopa—Venous thrombosis—Doxorubicin—liver cancer	0.00934	0.00951	CcSEcCtD
Carbidopa—Dysphagia—Sorafenib—liver cancer	0.00925	0.00942	CcSEcCtD
Carbidopa—Mesalazine—PPARG—liver cancer	0.00903	0.506	CrCbGaD
Carbidopa—Serum creatinine increased—Epirubicin—liver cancer	0.00886	0.00902	CcSEcCtD
Carbidopa—Weight decreased—Sorafenib—liver cancer	0.00837	0.00852	CcSEcCtD
Carbidopa—Serum creatinine increased—Doxorubicin—liver cancer	0.0082	0.00835	CcSEcCtD
Carbidopa—Acute coronary syndrome—Sorafenib—liver cancer	0.00813	0.00828	CcSEcCtD
Carbidopa—Myocardial infarction—Sorafenib—liver cancer	0.00809	0.00823	CcSEcCtD
Carbidopa—Neuropathy peripheral—Sorafenib—liver cancer	0.00809	0.00823	CcSEcCtD
Carbidopa—Hypokinesia—Epirubicin—liver cancer	0.00807	0.00822	CcSEcCtD
Carbidopa—Lung disorder—Epirubicin—liver cancer	0.0077	0.00784	CcSEcCtD
Carbidopa—Blister—Epirubicin—liver cancer	0.00756	0.0077	CcSEcCtD
Carbidopa—Hypokinesia—Doxorubicin—liver cancer	0.00747	0.00761	CcSEcCtD
Carbidopa—Haemoglobin—Sorafenib—liver cancer	0.00744	0.00758	CcSEcCtD
Carbidopa—Haemorrhage—Sorafenib—liver cancer	0.00741	0.00754	CcSEcCtD
Carbidopa—Urinary tract disorder—Sorafenib—liver cancer	0.00731	0.00745	CcSEcCtD
Carbidopa—Urethral disorder—Sorafenib—liver cancer	0.00726	0.00739	CcSEcCtD
Carbidopa—Lung disorder—Doxorubicin—liver cancer	0.00712	0.00725	CcSEcCtD
Carbidopa—Blister—Doxorubicin—liver cancer	0.007	0.00712	CcSEcCtD
Carbidopa—Flushing—Sorafenib—liver cancer	0.00687	0.007	CcSEcCtD
Carbidopa—Dysphonia—Epirubicin—liver cancer	0.00662	0.00674	CcSEcCtD
Carbidopa—Alopecia—Sorafenib—liver cancer	0.00654	0.00666	CcSEcCtD
Carbidopa—Mental disorder—Sorafenib—liver cancer	0.00649	0.00661	CcSEcCtD
Carbidopa—Dysgeusia—Sorafenib—liver cancer	0.00631	0.00643	CcSEcCtD
Carbidopa—Extravasation—Epirubicin—liver cancer	0.00625	0.00636	CcSEcCtD
Carbidopa—Muscle spasms—Sorafenib—liver cancer	0.0062	0.00631	CcSEcCtD
Carbidopa—Dysphonia—Doxorubicin—liver cancer	0.00613	0.00624	CcSEcCtD
Carbidopa—Anaemia—Sorafenib—liver cancer	0.00596	0.00607	CcSEcCtD
Carbidopa—Angioedema—Sorafenib—liver cancer	0.00589	0.006	CcSEcCtD
Carbidopa—Dyskinesia—Epirubicin—liver cancer	0.0058	0.0059	CcSEcCtD
Carbidopa—Syncope—Sorafenib—liver cancer	0.00578	0.00589	CcSEcCtD
Carbidopa—Extravasation—Doxorubicin—liver cancer	0.00578	0.00588	CcSEcCtD
Carbidopa—Leukopenia—Sorafenib—liver cancer	0.00577	0.00588	CcSEcCtD
Carbidopa—Loss of consciousness—Sorafenib—liver cancer	0.00567	0.00577	CcSEcCtD
Carbidopa—Cough—Sorafenib—liver cancer	0.00563	0.00573	CcSEcCtD
Carbidopa—Gait disturbance—Epirubicin—liver cancer	0.00558	0.00569	CcSEcCtD
Carbidopa—Hypertension—Sorafenib—liver cancer	0.00557	0.00567	CcSEcCtD
Carbidopa—Musculoskeletal pain—Epirubicin—liver cancer	0.00552	0.00562	CcSEcCtD
Carbidopa—Hiccups—Epirubicin—liver cancer	0.00545	0.00555	CcSEcCtD
Carbidopa—Dry mouth—Sorafenib—liver cancer	0.00537	0.00546	CcSEcCtD
Carbidopa—Dyskinesia—Doxorubicin—liver cancer	0.00537	0.00546	CcSEcCtD
Carbidopa—Salivary hypersecretion—Epirubicin—liver cancer	0.00529	0.00539	CcSEcCtD
Carbidopa—Infection—Sorafenib—liver cancer	0.00523	0.00532	CcSEcCtD
Carbidopa—Shock—Sorafenib—liver cancer	0.00518	0.00527	CcSEcCtD
Carbidopa—Gait disturbance—Doxorubicin—liver cancer	0.00517	0.00526	CcSEcCtD
Carbidopa—Thrombocytopenia—Sorafenib—liver cancer	0.00515	0.00524	CcSEcCtD
Carbidopa—Blood urea increased—Epirubicin—liver cancer	0.00515	0.00524	CcSEcCtD
Carbidopa—Musculoskeletal pain—Doxorubicin—liver cancer	0.0051	0.0052	CcSEcCtD
Carbidopa—Hiccups—Doxorubicin—liver cancer	0.00504	0.00513	CcSEcCtD
Carbidopa—Anorexia—Sorafenib—liver cancer	0.00502	0.00511	CcSEcCtD
Carbidopa—Salivary hypersecretion—Doxorubicin—liver cancer	0.0049	0.00499	CcSEcCtD
Carbidopa—Blood urea increased—Doxorubicin—liver cancer	0.00476	0.00485	CcSEcCtD
Carbidopa—Dyspnoea—Sorafenib—liver cancer	0.00469	0.00478	CcSEcCtD
Carbidopa—Dyspepsia—Sorafenib—liver cancer	0.00463	0.00472	CcSEcCtD
Carbidopa—Epinephrine—TNF—liver cancer	0.00462	0.259	CrCbGaD
Carbidopa—Phlebitis—Epirubicin—liver cancer	0.00459	0.00468	CcSEcCtD
Carbidopa—Decreased appetite—Sorafenib—liver cancer	0.00457	0.00466	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Sorafenib—liver cancer	0.00454	0.00462	CcSEcCtD
Carbidopa—Fatigue—Sorafenib—liver cancer	0.00454	0.00462	CcSEcCtD
Carbidopa—Constipation—Sorafenib—liver cancer	0.0045	0.00458	CcSEcCtD
Carbidopa—Pain—Sorafenib—liver cancer	0.0045	0.00458	CcSEcCtD
Carbidopa—Vascular purpura—Epirubicin—liver cancer	0.00442	0.0045	CcSEcCtD
Carbidopa—Gastrointestinal pain—Sorafenib—liver cancer	0.0043	0.00438	CcSEcCtD
Carbidopa—Phlebitis—Doxorubicin—liver cancer	0.00425	0.00433	CcSEcCtD
Carbidopa—Hot flush—Epirubicin—liver cancer	0.00423	0.00431	CcSEcCtD
Carbidopa—Menopausal symptoms—Epirubicin—liver cancer	0.00419	0.00427	CcSEcCtD
Carbidopa—Isoprenaline—CYP1A1—liver cancer	0.00418	0.234	CrCbGaD
Carbidopa—Urticaria—Sorafenib—liver cancer	0.00418	0.00426	CcSEcCtD
Carbidopa—Abdominal pain—Sorafenib—liver cancer	0.00416	0.00423	CcSEcCtD
Carbidopa—Body temperature increased—Sorafenib—liver cancer	0.00416	0.00423	CcSEcCtD
Carbidopa—Dermatitis bullous—Epirubicin—liver cancer	0.00414	0.00421	CcSEcCtD
Carbidopa—Purpura—Epirubicin—liver cancer	0.0041	0.00418	CcSEcCtD
Carbidopa—Vascular purpura—Doxorubicin—liver cancer	0.00409	0.00417	CcSEcCtD
Carbidopa—Hyponatraemia—Epirubicin—liver cancer	0.00397	0.00404	CcSEcCtD
Carbidopa—Diplopia—Epirubicin—liver cancer	0.00396	0.00403	CcSEcCtD
Carbidopa—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00396	0.00403	CcSEcCtD
Carbidopa—Pain in extremity—Epirubicin—liver cancer	0.00396	0.00403	CcSEcCtD
Carbidopa—Hot flush—Doxorubicin—liver cancer	0.00391	0.00398	CcSEcCtD
Carbidopa—Menopausal symptoms—Doxorubicin—liver cancer	0.00388	0.00395	CcSEcCtD
Carbidopa—Hypersensitivity—Sorafenib—liver cancer	0.00388	0.00395	CcSEcCtD
Carbidopa—Dermatitis bullous—Doxorubicin—liver cancer	0.00383	0.0039	CcSEcCtD
Carbidopa—Purpura—Doxorubicin—liver cancer	0.0038	0.00387	CcSEcCtD
Carbidopa—Asthenia—Sorafenib—liver cancer	0.00377	0.00384	CcSEcCtD
Carbidopa—Pruritus—Sorafenib—liver cancer	0.00372	0.00379	CcSEcCtD
Carbidopa—Ataxia—Epirubicin—liver cancer	0.00372	0.00379	CcSEcCtD
Carbidopa—Blood creatinine increased—Epirubicin—liver cancer	0.00371	0.00377	CcSEcCtD
Carbidopa—Hyponatraemia—Doxorubicin—liver cancer	0.00368	0.00374	CcSEcCtD
Carbidopa—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00366	0.00373	CcSEcCtD
Carbidopa—Pain in extremity—Doxorubicin—liver cancer	0.00366	0.00373	CcSEcCtD
Carbidopa—Diplopia—Doxorubicin—liver cancer	0.00366	0.00373	CcSEcCtD
Carbidopa—Orthostatic hypotension—Epirubicin—liver cancer	0.00361	0.00368	CcSEcCtD
Carbidopa—Diarrhoea—Sorafenib—liver cancer	0.0036	0.00367	CcSEcCtD
Carbidopa—Nasopharyngitis—Epirubicin—liver cancer	0.00354	0.0036	CcSEcCtD
Carbidopa—Gastritis—Epirubicin—liver cancer	0.0035	0.00356	CcSEcCtD
Carbidopa—Dizziness—Sorafenib—liver cancer	0.00348	0.00354	CcSEcCtD
Carbidopa—Ataxia—Doxorubicin—liver cancer	0.00344	0.0035	CcSEcCtD
Carbidopa—Blood creatinine increased—Doxorubicin—liver cancer	0.00343	0.00349	CcSEcCtD
Carbidopa—Dysphagia—Epirubicin—liver cancer	0.00342	0.00348	CcSEcCtD
Carbidopa—Vomiting—Sorafenib—liver cancer	0.00335	0.00341	CcSEcCtD
Carbidopa—Orthostatic hypotension—Doxorubicin—liver cancer	0.00334	0.0034	CcSEcCtD
Carbidopa—Rash—Sorafenib—liver cancer	0.00332	0.00338	CcSEcCtD
Carbidopa—Dermatitis—Sorafenib—liver cancer	0.00331	0.00337	CcSEcCtD
Carbidopa—Headache—Sorafenib—liver cancer	0.0033	0.00336	CcSEcCtD
Carbidopa—Nasopharyngitis—Doxorubicin—liver cancer	0.00327	0.00333	CcSEcCtD
Carbidopa—Gastritis—Doxorubicin—liver cancer	0.00324	0.0033	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Epirubicin—liver cancer	0.00318	0.00324	CcSEcCtD
Carbidopa—Dysphagia—Doxorubicin—liver cancer	0.00316	0.00322	CcSEcCtD
Carbidopa—Pollakiuria—Epirubicin—liver cancer	0.00316	0.00322	CcSEcCtD
Carbidopa—Nausea—Sorafenib—liver cancer	0.00313	0.00318	CcSEcCtD
Carbidopa—Weight increased—Epirubicin—liver cancer	0.00311	0.00317	CcSEcCtD
Carbidopa—Weight decreased—Epirubicin—liver cancer	0.00309	0.00315	CcSEcCtD
Carbidopa—Neuropathy peripheral—Epirubicin—liver cancer	0.00299	0.00304	CcSEcCtD
Carbidopa—Urinary tract infection—Epirubicin—liver cancer	0.00296	0.00302	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00294	0.00299	CcSEcCtD
Carbidopa—Pollakiuria—Doxorubicin—liver cancer	0.00292	0.00298	CcSEcCtD
Carbidopa—Weight increased—Doxorubicin—liver cancer	0.00288	0.00293	CcSEcCtD
Carbidopa—Weight decreased—Doxorubicin—liver cancer	0.00286	0.00291	CcSEcCtD
Carbidopa—Agranulocytosis—Epirubicin—liver cancer	0.00284	0.0029	CcSEcCtD
Carbidopa—Neuropathy peripheral—Doxorubicin—liver cancer	0.00277	0.00282	CcSEcCtD
Carbidopa—Haemoglobin—Epirubicin—liver cancer	0.00275	0.0028	CcSEcCtD
Carbidopa—Rhinitis—Epirubicin—liver cancer	0.00274	0.00279	CcSEcCtD
Carbidopa—Urinary tract infection—Doxorubicin—liver cancer	0.00274	0.00279	CcSEcCtD
Carbidopa—Haemorrhage—Epirubicin—liver cancer	0.00274	0.00279	CcSEcCtD
Carbidopa—Hypoaesthesia—Epirubicin—liver cancer	0.00272	0.00277	CcSEcCtD
Carbidopa—Urinary tract disorder—Epirubicin—liver cancer	0.0027	0.00275	CcSEcCtD
Carbidopa—Urethral disorder—Epirubicin—liver cancer	0.00268	0.00273	CcSEcCtD
Carbidopa—Agranulocytosis—Doxorubicin—liver cancer	0.00263	0.00268	CcSEcCtD
Carbidopa—Haemoglobin—Doxorubicin—liver cancer	0.00255	0.00259	CcSEcCtD
Carbidopa—Flushing—Epirubicin—liver cancer	0.00254	0.00259	CcSEcCtD
Carbidopa—Rhinitis—Doxorubicin—liver cancer	0.00254	0.00258	CcSEcCtD
Carbidopa—Haemorrhage—Doxorubicin—liver cancer	0.00253	0.00258	CcSEcCtD
Carbidopa—Hypoaesthesia—Doxorubicin—liver cancer	0.00252	0.00257	CcSEcCtD
Carbidopa—Urinary tract disorder—Doxorubicin—liver cancer	0.0025	0.00255	CcSEcCtD
Carbidopa—Urethral disorder—Doxorubicin—liver cancer	0.00248	0.00253	CcSEcCtD
Carbidopa—Alopecia—Epirubicin—liver cancer	0.00242	0.00246	CcSEcCtD
Carbidopa—Mental disorder—Epirubicin—liver cancer	0.0024	0.00244	CcSEcCtD
Carbidopa—Flushing—Doxorubicin—liver cancer	0.00235	0.00239	CcSEcCtD
Carbidopa—Flatulence—Epirubicin—liver cancer	0.00235	0.00239	CcSEcCtD
Carbidopa—Tension—Epirubicin—liver cancer	0.00234	0.00238	CcSEcCtD
Carbidopa—Dysgeusia—Epirubicin—liver cancer	0.00233	0.00238	CcSEcCtD
Carbidopa—Nervousness—Epirubicin—liver cancer	0.00231	0.00236	CcSEcCtD
Carbidopa—Back pain—Epirubicin—liver cancer	0.0023	0.00235	CcSEcCtD
Carbidopa—Muscle spasms—Epirubicin—liver cancer	0.00229	0.00233	CcSEcCtD
Carbidopa—Vision blurred—Epirubicin—liver cancer	0.00225	0.00229	CcSEcCtD
Carbidopa—Alopecia—Doxorubicin—liver cancer	0.00224	0.00228	CcSEcCtD
Carbidopa—Mental disorder—Doxorubicin—liver cancer	0.00222	0.00226	CcSEcCtD
Carbidopa—Ill-defined disorder—Epirubicin—liver cancer	0.00221	0.00225	CcSEcCtD
Carbidopa—Anaemia—Epirubicin—liver cancer	0.0022	0.00224	CcSEcCtD
Carbidopa—Agitation—Epirubicin—liver cancer	0.00219	0.00223	CcSEcCtD
Carbidopa—Flatulence—Doxorubicin—liver cancer	0.00217	0.00221	CcSEcCtD
Carbidopa—Tension—Doxorubicin—liver cancer	0.00216	0.0022	CcSEcCtD
Carbidopa—Dysgeusia—Doxorubicin—liver cancer	0.00216	0.0022	CcSEcCtD
Carbidopa—Malaise—Epirubicin—liver cancer	0.00215	0.00219	CcSEcCtD
Carbidopa—Nervousness—Doxorubicin—liver cancer	0.00214	0.00218	CcSEcCtD
Carbidopa—Syncope—Epirubicin—liver cancer	0.00214	0.00218	CcSEcCtD
Carbidopa—Leukopenia—Epirubicin—liver cancer	0.00213	0.00217	CcSEcCtD
Carbidopa—Back pain—Doxorubicin—liver cancer	0.00213	0.00217	CcSEcCtD
Carbidopa—Muscle spasms—Doxorubicin—liver cancer	0.00212	0.00216	CcSEcCtD
Carbidopa—Palpitations—Epirubicin—liver cancer	0.00211	0.00214	CcSEcCtD
Carbidopa—Loss of consciousness—Epirubicin—liver cancer	0.00209	0.00213	CcSEcCtD
Carbidopa—Cough—Epirubicin—liver cancer	0.00208	0.00212	CcSEcCtD
Carbidopa—Vision blurred—Doxorubicin—liver cancer	0.00208	0.00212	CcSEcCtD
Carbidopa—Convulsion—Epirubicin—liver cancer	0.00206	0.0021	CcSEcCtD
Carbidopa—Hypertension—Epirubicin—liver cancer	0.00206	0.00209	CcSEcCtD
Carbidopa—Ill-defined disorder—Doxorubicin—liver cancer	0.00205	0.00208	CcSEcCtD
Carbidopa—Anaemia—Doxorubicin—liver cancer	0.00204	0.00207	CcSEcCtD
Carbidopa—Chest pain—Epirubicin—liver cancer	0.00203	0.00207	CcSEcCtD
Carbidopa—Agitation—Doxorubicin—liver cancer	0.00203	0.00206	CcSEcCtD
Carbidopa—Anxiety—Epirubicin—liver cancer	0.00202	0.00206	CcSEcCtD
Carbidopa—Discomfort—Epirubicin—liver cancer	0.002	0.00204	CcSEcCtD
Carbidopa—Malaise—Doxorubicin—liver cancer	0.00199	0.00202	CcSEcCtD
Carbidopa—Dry mouth—Epirubicin—liver cancer	0.00198	0.00202	CcSEcCtD
Carbidopa—Syncope—Doxorubicin—liver cancer	0.00198	0.00201	CcSEcCtD
Carbidopa—Leukopenia—Doxorubicin—liver cancer	0.00197	0.00201	CcSEcCtD
Carbidopa—Confusional state—Epirubicin—liver cancer	0.00196	0.002	CcSEcCtD
Carbidopa—Palpitations—Doxorubicin—liver cancer	0.00195	0.00198	CcSEcCtD
Carbidopa—Oedema—Epirubicin—liver cancer	0.00194	0.00198	CcSEcCtD
Carbidopa—Loss of consciousness—Doxorubicin—liver cancer	0.00194	0.00197	CcSEcCtD
Carbidopa—Infection—Epirubicin—liver cancer	0.00193	0.00197	CcSEcCtD
Carbidopa—Cough—Doxorubicin—liver cancer	0.00192	0.00196	CcSEcCtD
Carbidopa—Shock—Epirubicin—liver cancer	0.00191	0.00195	CcSEcCtD
Carbidopa—Convulsion—Doxorubicin—liver cancer	0.00191	0.00194	CcSEcCtD
Carbidopa—Thrombocytopenia—Epirubicin—liver cancer	0.0019	0.00194	CcSEcCtD
Carbidopa—Hypertension—Doxorubicin—liver cancer	0.0019	0.00194	CcSEcCtD
Carbidopa—Hyperhidrosis—Epirubicin—liver cancer	0.00188	0.00191	CcSEcCtD
Carbidopa—Chest pain—Doxorubicin—liver cancer	0.00188	0.00191	CcSEcCtD
Carbidopa—Anxiety—Doxorubicin—liver cancer	0.00187	0.0019	CcSEcCtD
Carbidopa—Discomfort—Doxorubicin—liver cancer	0.00185	0.00189	CcSEcCtD
Carbidopa—Anorexia—Epirubicin—liver cancer	0.00185	0.00189	CcSEcCtD
Carbidopa—Dry mouth—Doxorubicin—liver cancer	0.00184	0.00187	CcSEcCtD
Carbidopa—Hypotension—Epirubicin—liver cancer	0.00182	0.00185	CcSEcCtD
Carbidopa—Confusional state—Doxorubicin—liver cancer	0.00181	0.00185	CcSEcCtD
Carbidopa—Oedema—Doxorubicin—liver cancer	0.0018	0.00183	CcSEcCtD
Carbidopa—Infection—Doxorubicin—liver cancer	0.00179	0.00182	CcSEcCtD
Carbidopa—Shock—Doxorubicin—liver cancer	0.00177	0.0018	CcSEcCtD
Carbidopa—Thrombocytopenia—Doxorubicin—liver cancer	0.00176	0.00179	CcSEcCtD
Carbidopa—Insomnia—Epirubicin—liver cancer	0.00176	0.00179	CcSEcCtD
Carbidopa—Paraesthesia—Epirubicin—liver cancer	0.00175	0.00178	CcSEcCtD
Carbidopa—Hyperhidrosis—Doxorubicin—liver cancer	0.00174	0.00177	CcSEcCtD
Carbidopa—Dyspnoea—Epirubicin—liver cancer	0.00173	0.00176	CcSEcCtD
Carbidopa—Somnolence—Epirubicin—liver cancer	0.00173	0.00176	CcSEcCtD
Carbidopa—Anorexia—Doxorubicin—liver cancer	0.00171	0.00175	CcSEcCtD
Carbidopa—Dyspepsia—Epirubicin—liver cancer	0.00171	0.00174	CcSEcCtD
Carbidopa—Decreased appetite—Epirubicin—liver cancer	0.00169	0.00172	CcSEcCtD
Carbidopa—Hypotension—Doxorubicin—liver cancer	0.00168	0.00171	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Epirubicin—liver cancer	0.00168	0.00171	CcSEcCtD
Carbidopa—Fatigue—Epirubicin—liver cancer	0.00168	0.00171	CcSEcCtD
Carbidopa—Pain—Epirubicin—liver cancer	0.00166	0.00169	CcSEcCtD
Carbidopa—Constipation—Epirubicin—liver cancer	0.00166	0.00169	CcSEcCtD
Carbidopa—Insomnia—Doxorubicin—liver cancer	0.00163	0.00166	CcSEcCtD
Carbidopa—Paraesthesia—Doxorubicin—liver cancer	0.00162	0.00164	CcSEcCtD
Carbidopa—Dyspnoea—Doxorubicin—liver cancer	0.0016	0.00163	CcSEcCtD
Carbidopa—Feeling abnormal—Epirubicin—liver cancer	0.0016	0.00163	CcSEcCtD
Carbidopa—Somnolence—Doxorubicin—liver cancer	0.0016	0.00163	CcSEcCtD
Carbidopa—Gastrointestinal pain—Epirubicin—liver cancer	0.00159	0.00162	CcSEcCtD
Carbidopa—Dyspepsia—Doxorubicin—liver cancer	0.00158	0.00161	CcSEcCtD
Carbidopa—Decreased appetite—Doxorubicin—liver cancer	0.00156	0.00159	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00155	0.00158	CcSEcCtD
Carbidopa—Fatigue—Doxorubicin—liver cancer	0.00155	0.00158	CcSEcCtD
Carbidopa—Urticaria—Epirubicin—liver cancer	0.00154	0.00157	CcSEcCtD
Carbidopa—Pain—Doxorubicin—liver cancer	0.00154	0.00157	CcSEcCtD
Carbidopa—Constipation—Doxorubicin—liver cancer	0.00154	0.00157	CcSEcCtD
Carbidopa—Abdominal pain—Epirubicin—liver cancer	0.00154	0.00156	CcSEcCtD
Carbidopa—Body temperature increased—Epirubicin—liver cancer	0.00154	0.00156	CcSEcCtD
Carbidopa—Feeling abnormal—Doxorubicin—liver cancer	0.00148	0.00151	CcSEcCtD
Carbidopa—Gastrointestinal pain—Doxorubicin—liver cancer	0.00147	0.0015	CcSEcCtD
Carbidopa—Hypersensitivity—Epirubicin—liver cancer	0.00143	0.00146	CcSEcCtD
Carbidopa—Urticaria—Doxorubicin—liver cancer	0.00143	0.00146	CcSEcCtD
Carbidopa—Abdominal pain—Doxorubicin—liver cancer	0.00142	0.00145	CcSEcCtD
Carbidopa—Body temperature increased—Doxorubicin—liver cancer	0.00142	0.00145	CcSEcCtD
Carbidopa—Asthenia—Epirubicin—liver cancer	0.0014	0.00142	CcSEcCtD
Carbidopa—Pruritus—Epirubicin—liver cancer	0.00138	0.0014	CcSEcCtD
Carbidopa—Diarrhoea—Epirubicin—liver cancer	0.00133	0.00135	CcSEcCtD
Carbidopa—Hypersensitivity—Doxorubicin—liver cancer	0.00133	0.00135	CcSEcCtD
Carbidopa—Asthenia—Doxorubicin—liver cancer	0.00129	0.00131	CcSEcCtD
Carbidopa—Dizziness—Epirubicin—liver cancer	0.00129	0.00131	CcSEcCtD
Carbidopa—Pruritus—Doxorubicin—liver cancer	0.00127	0.0013	CcSEcCtD
Carbidopa—Vomiting—Epirubicin—liver cancer	0.00124	0.00126	CcSEcCtD
Carbidopa—Diarrhoea—Doxorubicin—liver cancer	0.00123	0.00125	CcSEcCtD
Carbidopa—Rash—Epirubicin—liver cancer	0.00123	0.00125	CcSEcCtD
Carbidopa—Dermatitis—Epirubicin—liver cancer	0.00122	0.00125	CcSEcCtD
Carbidopa—Headache—Epirubicin—liver cancer	0.00122	0.00124	CcSEcCtD
Carbidopa—Dizziness—Doxorubicin—liver cancer	0.00119	0.00121	CcSEcCtD
Carbidopa—Nausea—Epirubicin—liver cancer	0.00115	0.00118	CcSEcCtD
Carbidopa—Vomiting—Doxorubicin—liver cancer	0.00114	0.00116	CcSEcCtD
Carbidopa—Rash—Doxorubicin—liver cancer	0.00113	0.00115	CcSEcCtD
Carbidopa—Dermatitis—Doxorubicin—liver cancer	0.00113	0.00115	CcSEcCtD
Carbidopa—Headache—Doxorubicin—liver cancer	0.00113	0.00115	CcSEcCtD
Carbidopa—Nausea—Doxorubicin—liver cancer	0.00107	0.00109	CcSEcCtD
